Wiggin and Dana Represents Meda AB in 3M's $2.1 billion Divestment of 3M's Pharmaceutical Business

November 10, 2006

STAMFORD, CT. - Meda AB,  a leading European specialty pharmaceutical company, announced it will acquire 3M's European pharmaceutical business for $857 million.  Pending regulatory approval, the transaction will close in late 2006 or early 2007.